Source link : https://www.newshealth.biz/health-news/filgotinib-maintains-ra-efficacy-for-3-years-no-new-safety-issues/
Filgotinib, the rheumatoid arthritis (RA) oral drug that never made it to the U.S. market but is sold across Europe, Great Britain, and Japan, remained effective for 3 years for most registration trial participants who continued in a long-term extension study, researchers said. In the so-called FINCH 4 study, ACR20 responses (20% reduction in symptoms […]
Author : News Health
Publish date : 2024-10-28 20:24:14
Copyright for syndicated content belongs to the linked Source.
